MARKET

TRIB

TRIB

Trinity Biotech Plc
NASDAQ
7.37
-0.42
-5.39%
Opening 14:02 09/11 EDT
OPEN
7.99
PREV CLOSE
7.79
HIGH
7.99
LOW
6.85
VOLUME
6.89K
TURNOVER
--
52 WEEK HIGH
52.50
52 WEEK LOW
6.85
MARKET CAP
5.99M
P/E (TTM)
-0.1221
1D
5D
1M
3M
1Y
5Y
1D
Trinity Biotech Signs Contract With Red Team Investments For AI Data Center Cooling Solutions
NASDAQ · 2d ago
Trinity Biotech’s Trinovium Unit Signs AI Data Center Cooling Pilot Deal with Red Team Investments
TipRanks · 2d ago
Trinity Biotech's Liquid Cooling Unit Trinovium Enters Contract With Red Team Investments, Owner Of Modular Data Center Technology X-MDC
Benzinga · 2d ago
Trinity Biotech Files 2025 Annual Report and AGM Materials with SEC
TipRanks · 2d ago
Weekly Report: what happened at TRIB last week (0831-0904)?
Weekly Report · 4d ago
Trinity Issues Updates On Diagnostics Launch; Plans To Regain Nasdaq Compliance By Feb '27
NASDAQ · 08/31 16:10
Weekly Report: what happened at TRIB last week (0824-0828)?
Weekly Report · 08/31 09:22
Trinity Biotech Advances Diagnostics Transformation as Nasdaq Compliance Pressure Mounts
TipRanks · 08/28 21:47
More
About TRIB
Trinity Biotech plc is a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and to quantify the level of Hemoglobin A1c and other chemical parameters in serum, plasma and whole blood, and the Company intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product. Its TrinScreen Human Immunodeficiency Virus (HIV) rapid point-of-care test is a high-quality, single-use immunoassays to aid in the diagnosis of HIV. The Uni-Gold range of rapid point-of-care test devices consist of high-quality, single-use immunoassays to aid in the diagnosis of HIV.

Webull offers Trinity Biotech PLC (ADR) stock information, including NASDAQ: TRIB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TRIB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TRIB stock methods without spending real money on the virtual paper trading platform.